Whether a biopharmaceutical company is large or small, supply chains are complicated and difficult to manage. A typical multi-vendor development plan might have as many as 10 different potential sources of time and cost inefficiencies. These areas may include sourcing materials from multiple vendors, working out various project details and timelines, negotiating numerous vendor contracts, revalidating numerous steps of the process, documenting drug product testing from early stages and more. Coordinating tech transfers between parties adds another layer of stress, effort and potential problems.
When customers consolidate their supply chain and use one vendor from drug substance through drug product, it can transform the entire drug development process into a more efficient system with cost and timeline advantages as well as potentially an even better end-product.